The next generation of liposome delivery systems: Recent experience with tumor-targeted, sterically-stabilized immunoliposomes and active-loading gradients

Journal of Liposome Research

Volumn 12, Issue 1-2, 2002, Pages 1-3

  Abra, R M ^a   Bankert, R B ^c   Chen, F ^b   Egilmez, N K ^b   Huang, K ^a   Saville, R ^a   Slater, J L ^a   Sugano, M ^b   Yokota, S J ^b  

^a ALZA CORPORATION   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN DERIVATIVE; CISPLATIN; DOXORUBICIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOLIPOSOME; INTEGRIN; MALEIMIDE;

ANTINEOPLASTIC ACTIVITY; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; HUMAN; PRIORITY JOURNAL; STEREOCHEMISTRY;

AMMONIUM SULFATE; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CISPLATIN; DEXTRANS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; LIGANDS; LIPID BILAYERS; LIPOSOMES;

EID: 0036334957     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.1081/LPR-120004770     Document Type: Conference Paper

References (3)

1. Targeted sterically stabilized liposomal drug delivery
2. Liposome application: Problems and prospects
3. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice